Last reviewed · How we verify

NCT05055271

Delphi Consensus Excessive Daytime Sleepiness in OSA

Completed Last updated 10 October 2023
What this trial tests

trial in Obstructive Sleep Apnea in 10 participants. Completed in 12 September 2022.

Timeline
1 April 2021
Primary endpoint
12 September 2022
12 September 2022

Quick facts

Lead sponsorKing's College London
StatusCompleted
Study typeOBSERVATIONAL
Enrollment10
Start date1 April 2021
Primary completion12 September 2022
Estimated completion12 September 2022
Sites1 location across United Kingdom

Conditions studied

Sponsor

King's College London

Who can join

19 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to generate expert consensus statements on the differential diagnosis, definition, and management of EDS in patients with OSA who are adequately treated with primary therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea - A Delphi consensus study.
    Steier JS, Bogan RK, Cano-Pumarega IM, Fleetham JA, et al · · 2023 · cited 13× · PMID 37839271 · DOI 10.1016/j.sleep.2023.10.001

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other King's College London trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05055271.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing